Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Pump the brakes: identifying neurobiological targets to enhance inhibitory control in drug addiction
    Published on 2024-07-17
    12 months ago
  • Brain-based graph-theoretical predictive modeling: a novel approach to prospectively map psychiatric symptoms
    Published on 2024-07-16
    12 months ago
  • Oxytocin treatment rescues irritability-like behavior in Cc2d1a conditional knockout mice
    Published on 2024-07-16
    12 months ago
  • Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats
    Published on 2024-07-06
    1 year ago
  • Advancement in human neuroimaging based on proximity ligation assay in brain disease
    Published on 2024-07-02
    1 year ago
  • Interaction of perceived social support and childhood maltreatment on limbic responsivity towards negative emotional stimuli in healthy individuals
    Published on 2024-07-01
    1 year ago
  • Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression
    Published on 2024-07-01
    1 year ago
« Previous 1 … 35 36 37 38 39 … 143 Next »
Journal of Psychopharmacology
  • Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers
    Published on 2023-07-04
    2 years ago
  • Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice
    Published on 2023-07-03
    2 years ago
  • Psilocybin’s effects on cognition and creativity: A scoping review
    Published on 2023-07-03
    2 years ago
  • Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
    Published on 2023-07-01
    2 years ago
  • Harnessing placebo: Lessons from psychedelic science
    Published on 2023-07-01
    2 years ago
  • Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia
    Published on 2023-06-28
    2 years ago
  • The New Zealand drug harms ranking study: A multi-criteria decision analysis
    Published on 2023-06-24
    2 years ago
« Previous 1 … 35 36 37 38 39 … 124 Next »
European Neuropsychopharmacology
  • Controversies about ADHD: Early or also late-onset? Neurodevelopmental or also stress-related?
    Published on 2023-09-01
    2 years ago
  • The polygenic basis of relapse after a first episode of schizophrenia
    Published on 2023-08-20
    2 years ago
  • Biological markers of sex-based differences in major depressive disorder and in antidepressant response
    Published on 2023-08-17
    2 years ago
  • Effects of cannabis use on antidepressant treatment response to repetitive transcranial magnetic stimulation and ketamine
    Published on 2023-08-14
    2 years ago
  • Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls
    Published on 2023-08-09
    2 years ago
  • Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
    Published on 2023-08-08
    2 years ago
  • Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia
    Published on 2023-08-07
    2 years ago
« Previous 1 … 35 36 37 38 39 … 144 Next »

   Pharma Pub